{"DataElement":{"publicId":"5040656","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Feature Present Type","preferredDefinition":"A description of the chronic graft versus host disease skin feature that was present.","longName":"5040633v1.0:5040652v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5040633","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Feature Present","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation._An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages._A prominent or identifiable aspect, region, or site of interest._Being or existing in a specified place or at the specified time.","longName":"5040655v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5040655","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Feature","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.:An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.:A prominent or identifiable aspect, region, or site of interest.","longName":"C4981:C12470:C73619","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2353FFBF-35C9-EAC9-E050-BB89AD434F78","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23532D15-5E5C-27F3-E050-BB89AD435DF4","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5040652","version":"1","preferredName":"Graft Versus Host Disease Skin Feature Type","preferredDefinition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation._An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages._A prominent or identifiable aspect, region, or site of interest._Something distinguishable as an identifiable class based on common qualities.","longName":"5040652v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Lichen planus-like features","valueDescription":"Lichen Planus-Like Features","ValueMeaning":{"publicId":"5040653","version":"1","preferredName":"Lichen Planus-Like Features","longName":"5040653","preferredDefinition":"An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a \"saw-tooth\" pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.: A prominent or identifiable aspect, region, or site of interest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lichen Planus","conceptCode":"C3189","definition":"A chronic, recurrent, pruritic inflammatory disorder of unknown etiology that affects the skin and mucus membranes. It presents with rashes and papules that tend to resolve spontaneously. It may be associated with hepatitis C. Certain drugs that contain arsenic or bismuth are associated with reactions mimicking lichen planus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23532D15-5E9B-27F3-E050-BB89AD435DF4","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23532D15-5EB4-27F3-E050-BB89AD435DF4","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"},{"value":"Maculopapular rash / erythema","valueDescription":"Maculopapular Lesion Or Erythema","ValueMeaning":{"publicId":"5040654","version":"1","preferredName":"Maculopapular Lesion Or Erythema","longName":"5040654","preferredDefinition":"A skin condition consisting of both macules and papules.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maculopapular Lesion","conceptCode":"C75579","definition":"A skin condition consisting of both macules and papules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Erythema","conceptCode":"C26901","definition":"Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23532D15-5EC2-27F3-E050-BB89AD435DF4","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D001A62-D5E7-0510-E050-BB89AD437747","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-01","modifiedBy":"ONEDATA","dateModified":"2016-03-01","deletedIndicator":"No"},{"value":"Keratosis pilaris-like GVHD","valueDescription":"Keratosis Pilaris","ValueMeaning":{"publicId":"5042256","version":"1","preferredName":"Keratosis Pilaris","longName":"5042256","preferredDefinition":"A very common, non-neoplastic dermatologic disorder characterized by keratinization of hair follicles of the skin. It manifests as small, rough folliculocentric keratotic papules, usually in the outer-upper arms and thighs. It affects children and adolescents and usually improves with age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Keratosis Pilaris","conceptCode":"C124070","definition":"A very common, non-neoplastic dermatologic disorder characterized by keratinization of hair follicles of the skin. It manifests as small, rough folliculocentric keratotic papules, usually in the outer-upper arms and thighs. It affects children and adolescents and usually improves with age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A55A6C-EB13-3D7E-E050-BB89AD437DF8","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23A55A6C-EB2C-3D7E-E050-BB89AD437DF8","beginDate":"2015-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-03","modifiedBy":"ONEDATA","dateModified":"2015-11-03","deletedIndicator":"No"},{"value":"Papulosquamous lesions or ichthyosis","valueDescription":"Papulosquamous Lesion Or Ichthyosis","ValueMeaning":{"publicId":"5042257","version":"1","preferredName":"Papulosquamous Lesion Or Ichthyosis","longName":"5042257","preferredDefinition":"A skin lesion characterized by the presence of scaly papules and plaques.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A group of inherited or acquired skin disorders characterized by a dry, thickened, and scaly skin. The skin changes range from mild to severe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papulosquamous Lesion","conceptCode":"C124069","definition":"A skin lesion characterized by the presence of scaly papules and plaques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ichthyosis","conceptCode":"C84776","definition":"A group of inherited or acquired skin disorders characterized by a dry, thickened, and scaly skin. The skin changes range from mild to severe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A55A6C-EB3A-3D7E-E050-BB89AD437DF8","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23A55A6C-EB53-3D7E-E050-BB89AD437DF8","beginDate":"2015-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-03","modifiedBy":"ONEDATA","dateModified":"2015-11-03","deletedIndicator":"No"},{"value":"Sclerotic features","valueDescription":"Sclerosis Feature","ValueMeaning":{"publicId":"5505459","version":"1","preferredName":"Sclerosis Feature","longName":"5505459","preferredDefinition":"A pathological hardening or thickening of tissue, especially that of the interstitial substance.: A prominent or identifiable aspect, region, or site of interest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sclerosis","conceptCode":"C69309","definition":"A pathological hardening or thickening of tissue, especially that of the interstitial substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E22DAEE-383B-12AC-E053-F662850AB1FD","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42AFF649-601B-388A-E053-F662850A1FA9","beginDate":"2016-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-02","modifiedBy":"ONEDATA","dateModified":"2016-12-02","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"4001711","version":"1","preferredName":"None","longName":"4001711","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6DCE6B-B411-EF30-E040-BB89AD4369A8","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-12-13","modifiedBy":"GDEEN","dateModified":"2024-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF54F140-B31F-6FB2-E053-4EBD850A8251","beginDate":"2021-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-04-06","modifiedBy":"ONEDATA","dateModified":"2021-04-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5040651","version":"1","preferredName":"Graft Versus Host Disease Skin Feature Type","preferredDefinition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.:An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.:A prominent or identifiable aspect, region, or site of interest.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3063:C12470:C73619:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23532D15-5E74-27F3-E050-BB89AD435DF4","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23532D15-5E85-27F3-E050-BB89AD435DF4","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"MALUMK","dateModified":"2021-04-06","changeDescription":".PV added for 2100r7. 04/06/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HPST_CGHD_cgvhd_skin_feat_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the chronic graft ve","type":"Preferred Question Text","description":"What was the chronic graft versus host disease skin feature that was present?","url":null,"context":"NHLBI"},{"name":"Specify skin GVHD features present at diagnosis of chronic GVHD","type":"Alternate Question Text","description":"Specify skin GVHD features present at diagnosis of chronic GVHD","url":null,"context":"NHLBI"},{"name":"Specify skin GVHD features present","type":"Application Standard Question Text","description":"Specify skin GVHD features present","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2353FFBF-35DD-EAC9-E050-BB89AD434F78","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"MALUMK","dateModified":"2021-10-04","changeDescription":".AQT added for 2100r7. 03/25/2021 KMM. ALT name added for 2100r7. 10/04/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}